CCTR interviews Jonathan Agin and Charles Keller MD of CC-TDI

Thursday, Feb. 4 CCTR interviews Jonathan Agin, Development Liaison and General Counsel for the Children's Cancer Therapy Development Institute, or CC-TDI, a non-profit biotech company dedicated to eradicating childhood cancer in all its forms.  Jonathan is an attorney by trade and has become one of the united State's foremost advocates for children with cancer following the death of his daughter Alexis in January of 2011.  Scientific Director Charles Keller MD also joins us to describe the very innovative and proactive design of this company, addressing the "pre-clinical gap" in our medical research system that has resulted in the neglect of the deadliest childhood cancers, many of which have been awaiting effective therapy development for decades.  For more guest info, visit:

To support Jack's Angels campaign for DIPG research at CCTDI, visit:

Return to the Childhood Cancer Talk Radio Podcast Page
Connect with Us

Visit Us

About Janet

Blessed with varied interests and an artistic and musical upbringing, Janet had health challenges throughout her young adult life. Despite these she graduated Cum Laude from Wellesley College with an award of distinction for acting, and had also been a champion equestrian. She began a family with her husband Barry later in life, and had finally found happiness with daughter Sophie-Marie (3/12/06) and then baby (Jack 8/30/08). Five weeks after his birth, the family escaped a wildfire in which all worldly possessions were lost. The family relocated in December of 2008 to Agua Dulce CA where they currently reside.

Jack began to have unsettling symptoms at the age of 3; he was taken to Children's Hospital Los Angeles and was diagnosed with DIPG, or diffuse intrinsic pontine glioma, on Friday Oct. 28, 2011, indisputably the darkest experience of Janet's life. The outrage of it made her determined to find the good in the situation, and she asked God to "Put me to work!" After Jack's death, she remained determined to start working to find solutions to DIPG and incorporated Jack's Angels at the end of 2012; the Foundation began its work in 2013. Despite the fact that DIPG is responsible for the majority of brain tumor deaths in children, she had been told there were no solutions for Jack because "the numbers aren't great enough for investors." This remains the primary motivation in her advocacy work, to prioritize children's lives in our medical system in the United States.